{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:44:28Z","timestamp":1787067868761,"version":"build-2736575974"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.bioorg.2021.105489","type":"journal-article","created":{"date-parts":[[2021,11,14]],"date-time":"2021-11-14T09:47:23Z","timestamp":1636883243000},"page":"105489","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Design, synthesis and biological evaluation of substituted 3-amino-N-(thiazol-2-yl)pyrazine-2-carboxamides as inhibitors of mycobacterial methionine aminopeptidase 1"],"prefix":"10.1016","volume":"118","author":[{"given":"Martin","family":"Juh\u00e1s","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod S.K.","family":"Pallabothula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarina","family":"Grabrijan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"\u0160imovi\u010dov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ond\u0159ej","family":"Jan\u010fourek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kl\u00e1ra","family":"Kone\u010dn\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"B\u00e1rta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavla","family":"Paterov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanislav","family":"Gobec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izidor","family":"Sosi\u010d","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Zitko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2021.105489_b0005","unstructured":"Geneva: World Health Organization, Global Tuberculosis Report 2020, 2020."},{"issue":"3","key":"10.1016\/j.bioorg.2021.105489_b0010","first-page":"210","article-title":"Nontuberculous mycobacterial pulmonary infections","volume":"6","author":"Johnson","year":"2014","journal-title":"J. Thorac. Dis."},{"issue":"6","key":"10.1016\/j.bioorg.2021.105489_b0015","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaa173","article-title":"Characteristics of Nontuberculous Mycobacterial Infections at a Midwestern Tertiary Hospital: A Retrospective Study of 365 Patients","volume":"7","author":"Hannah","year":"2020","journal-title":"Open Forum Infectious Diseases"},{"issue":"13","key":"10.1016\/j.bioorg.2021.105489_b0020","doi-asserted-by":"crossref","first-page":"4958","DOI":"10.1073\/pnas.1403078111","article-title":"Mycobacterial outer membrane is a lipid bilayer and the inner membrane is unusually rich in diacyl phosphatidylinositol dimannosides","volume":"111","author":"Bansal-Mutalik","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bioorg.2021.105489_b0025","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/139127","article-title":"The tuberculous granuloma: an unsuccessful host defence mechanism providing a safety shelter for the bacteria?","author":"Silva Miranda","year":"2012","journal-title":"Clin. Dev. Immunol."},{"issue":"1","key":"10.1016\/j.bioorg.2021.105489_b0030","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1128\/AAC.05208-11","article-title":"Pharmacokinetic evaluation of the penetration of antituberculosis agents in rabbit pulmonary lesions","volume":"56","author":"Kjellsson","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bioorg.2021.105489_b0035","unstructured":"Geneva: World Health Organization, Guidelines for treatment of drug-susceptible tuberculosis and patient care (2017 update), 2017."},{"issue":"7","key":"10.1016\/j.bioorg.2021.105489_b0040","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1093\/cid\/ciw376","article-title":"Official American Thoracic Society\/Centers for Disease Control and Prevention\/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis","volume":"63","author":"Nahid","year":"2016","journal-title":"Clin. Infect. Dis."},{"issue":"6","key":"10.1016\/j.bioorg.2021.105489_b0045","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1002\/jcb.20493","article-title":"Methionine aminopeptidases type I and type II are essential to control cell proliferation","volume":"95","author":"Bernier","year":"2005","journal-title":"J. Cell. Biochem."},{"issue":"7","key":"10.1016\/j.bioorg.2021.105489_b0050","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.1128\/jb.171.7.4071-4072.1989","article-title":"Methionine aminopeptidase gene of Escherichia coli is essential for cell growth","volume":"171","author":"Chang","year":"1989","journal-title":"J. Bacteriol."},{"issue":"5","key":"10.1016\/j.bioorg.2021.105489_b0055","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3390\/cells8050393","article-title":"MapB Protein is the Essential Methionine Aminopeptidase in Mycobacterium tuberculosis","volume":"8","author":"Vanunu","year":"2019","journal-title":"Cells"},{"issue":"9","key":"10.1016\/j.bioorg.2021.105489_b0060","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1016\/j.bmcl.2010.03.067","article-title":"Expression and characterization of Mycobacterium tuberculosis methionine aminopeptidase type 1a","volume":"20","author":"Lu","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.bioorg.2021.105489_b0065","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.chembiol.2009.12.014","article-title":"Methionine aminopeptidases from Mycobacterium tuberculosis as novel antimycobacterial targets","volume":"17","author":"Olaleye","year":"2010","journal-title":"Chem. Biol."},{"issue":"13","key":"10.1016\/j.bioorg.2021.105489_b0070","doi-asserted-by":"crossref","first-page":"5295","DOI":"10.1021\/jm400395p","article-title":"Identification, biochemical and structural evaluation of species-specific inhibitors against type I methionine aminopeptidases","volume":"56","author":"Kishor","year":"2013","journal-title":"J. Med. Chem."},{"issue":"11","key":"10.1016\/j.bioorg.2021.105489_b0075","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1039\/c2md20096a","article-title":"Structural studies of Enterococcus faecalis methionine aminopeptidase and design of microbe specific 2,2 '-bipyridine based inhibitors","volume":"3","author":"Kishor","year":"2012","journal-title":"Medchemcomm"},{"issue":"40","key":"10.1016\/j.bioorg.2021.105489_b0080","doi-asserted-by":"crossref","first-page":"26879","DOI":"10.1074\/jbc.M804345200","article-title":"FE(II) is the native cofactor for Escherichia coli methionine aminopeptidase","volume":"283","author":"Chai","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"19","key":"10.1016\/j.bioorg.2021.105489_b0085","doi-asserted-by":"crossref","first-page":"6110","DOI":"10.1021\/jm8005788","article-title":"Discovery of inhibitors of Escherichia coli methionine aminopeptidase with the Fe(II)-form selectivity and antibacterial activity","volume":"51","author":"Wang","year":"2008","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2021.105489_b0090","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2174\/1568026615666150813145410","article-title":"Advances in Bacterial Methionine Aminopeptidase Inhibition","volume":"16","author":"R. Helgren","year":"2015","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105489_b0095","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1471-2091-10-32","article-title":"Analysis of the stoichiometric metal activation of methionine aminopeptidase","volume":"10","author":"Chai","year":"2009","journal-title":"BMC Biochem."},{"issue":"25","key":"10.1016\/j.bioorg.2021.105489_b0100","doi-asserted-by":"crossref","first-page":"9470","DOI":"10.1073\/pnas.0602433103","article-title":"Structural basis of catalysis by monometalated methionine aminopeptidase","volume":"103","author":"Ye","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"13","key":"10.1016\/j.bioorg.2021.105489_b0105","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.1021\/bi9925827","article-title":"Divalent metal binding properties of the methionyl aminopeptidase from Escherichia coli","volume":"39","author":"D'souza","year":"2000","journal-title":"Biochemistry"},{"issue":"23","key":"10.1016\/j.bioorg.2021.105489_b0110","doi-asserted-by":"crossref","first-page":"5735","DOI":"10.1021\/jm700930k","article-title":"Inhibition of monometalated methionine aminopeptidase: inhibitor discovery and crystallographic analysis","volume":"50","author":"Huang","year":"2007","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2021.105489_b0115","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1002\/cmdc.201100003","article-title":"Inhibition of Mycobacterium tuberculosis methionine aminopeptidases by bengamide derivatives","volume":"6","author":"Lu","year":"2011","journal-title":"ChemMedChem"},{"issue":"14","key":"10.1016\/j.bioorg.2021.105489_b0120","doi-asserted-by":"crossref","first-page":"4038","DOI":"10.1016\/j.bmcl.2010.05.093","article-title":"Subtype-selectivity of metal-dependent methionine aminopeptidase inhibitors","volume":"20","author":"Altmeyer","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"3","key":"10.1016\/j.bioorg.2021.105489_b0125","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.bmcl.2004.11.034","article-title":"Inhibitors of type I MetAPs containing pyridine-2-carboxylic acid thiazol-2-ylamide. Part 1: SAR studies on the determination of the key scaffold","volume":"15","author":"Luo","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"18","key":"10.1016\/j.bioorg.2021.105489_b0130","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1016\/j.bmcl.2005.06.005","article-title":"Identification of potent type I MetAPs inhibitors by simple bioisosteric replacement. Part 2: SAR studies of 5-heteroalkyl substituted TCAT derivatives","volume":"15","author":"Cui","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"16","key":"10.1016\/j.bioorg.2021.105489_b0135","doi-asserted-by":"crossref","first-page":"3732","DOI":"10.1016\/j.bmcl.2005.05.055","article-title":"Identification of potent type I MetAP inhibitors by simple bioisosteric replacement. Part 1: Synthesis and preliminary SAR studies of thiazole-4-carboxylic acid thiazol-2-ylamide derivatives","volume":"15","author":"Cui","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"13","key":"10.1016\/j.bioorg.2021.105489_b0140","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1021\/jm0300532","article-title":"Discovery and structural modification of inhibitors of methionine aminopeptidases from Escherichia coli and Saccharomyces cerevisiae","volume":"46","author":"Luo","year":"2003","journal-title":"J. Med. Chem."},{"issue":"48","key":"10.1016\/j.bioorg.2021.105489_b0145","doi-asserted-by":"crossref","first-page":"18148","DOI":"10.1073\/pnas.0608389103","article-title":"Elucidation of the function of type 1 human methionine aminopeptidase during cell cycle progression","volume":"103","author":"Hu","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.bioorg.2021.105489_b0150","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3390\/11040242","article-title":"Substituted pyrazinecarboxamides: synthesis and biological evaluation","volume":"11","author":"Dolezal","year":"2006","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.bioorg.2021.105489_b0155","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.tube.2012.06.001","article-title":"Salicylanilide derivatives block Mycobacterium tuberculosis through inhibition of isocitrate lyase and methionine aminopeptidase","volume":"92","author":"Kr\u00e1tk\u00fd","year":"2012","journal-title":"Tuberculosis (Edinb)"},{"issue":"7","key":"10.1016\/j.bioorg.2021.105489_b0160","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.3390\/molecules25071518","article-title":"N-Pyrazinoyl Substituted Amino Acids as Potential Antimycobacterial Agents-The Synthesis and Biological Evaluation of Enantiomers","volume":"25","author":"Juhas","year":"2020","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.bioorg.2021.105489_b0165","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3390\/molecules22020223","article-title":"Synthesis of Novel Pyrazinamide Derivatives Based on 3-Chloropyrazine-2-carboxamide and Their Antimicrobial Evaluation","volume":"22","author":"Jandourek","year":"2017","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.bioorg.2021.105489_b0170","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3390\/molecules22030495","article-title":"3-Substituted N-Benzylpyrazine-2-carboxamide Derivatives: Synthesis, Antimycobacterial and Antibacterial Evaluation","volume":"22","author":"Semelkova","year":"2017","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.bioorg.2021.105489_b0175","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1039\/C8MD00056E","article-title":"Design, synthesis and antimycobacterial activity of hybrid molecules combining pyrazinamide with a 4-phenylthiazol-2-amine scaffold","volume":"9","author":"Zitko","year":"2018","journal-title":"Medchemcomm"},{"issue":"7","key":"10.1016\/j.bioorg.2021.105489_b0180","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24071212","article-title":"Derivatives of 3-Aminopyrazine-2-carboxamides: Synthesis, Antimicrobial Evaluation, and in Vitro Cytotoxicity","volume":"24","author":"Bouz","year":"2019","journal-title":"Molecules"},{"issue":"Suppl 1","key":"10.1016\/j.bioorg.2021.105489_b0185","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1016\/j.tube.2011.10.012","article-title":"Characterization of clioquinol and analogues as novel inhibitors of methionine aminopeptidases from Mycobacterium tuberculosis","volume":"91","author":"Olaleye","year":"2011","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.bioorg.2021.105489_b0190","doi-asserted-by":"crossref","unstructured":"H. Wamhoff, E. Kroth, Dihalogentriphenylphosphoranes in the Synthesis of Heterocycles .29. A Simple Synthesis of Pteridin-4-Ones, from Methyl 3-Amino-2-Pyrazinecarboxylate and Pyrazino[3,1]Oxazin-4-Ones, Synthesis-Stuttgart (4) (1994) 405-410.","DOI":"10.1055\/s-1994-25487"},{"issue":"3","key":"10.1016\/j.bioorg.2021.105489_b0195","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1021\/jm901624n","article-title":"Catalysis and inhibition of Mycobacterium tuberculosis methionine aminopeptidase","volume":"53","author":"Lu","year":"2010","journal-title":"J. Med. Chem."},{"issue":"43","key":"10.1016\/j.bioorg.2021.105489_b0200","doi-asserted-by":"crossref","first-page":"13940","DOI":"10.1021\/ja045864p","article-title":"Metalloform-selective inhibitors of escherichia coli methionine aminopeptidase and X-ray structure of a Mn(II)-form enzyme complexed with an inhibitor","volume":"126","author":"Ye","year":"2004","journal-title":"J. Am. Chem. Soc."},{"issue":"2","key":"10.1016\/j.bioorg.2021.105489_b0205","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.bbrc.2005.11.042","article-title":"Metal mediated inhibition of methionine aminopeptidase by quinolinyl sulfonamides","volume":"339","author":"Huang","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"issue":"17","key":"10.1016\/j.bioorg.2021.105489_b0210","doi-asserted-by":"crossref","first-page":"8901","DOI":"10.1021\/acs.jmedchem.9b02021","article-title":"Molecular Interactions of Pyrazine-Based Compounds to Proteins","volume":"63","author":"Juh\u00e1s","year":"2020","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2021.105489_b0215","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1128\/JCM.36.2.362-366.1998","article-title":"Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate Alamar Blue assay","volume":"36","author":"Franzblau","year":"1998","journal-title":"J. Clin. Microbiol."},{"issue":"9","key":"10.1016\/j.bioorg.2021.105489_b0220","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.jiph.2020.06.023","article-title":"Features of the biochemistry of Mycobacterium smegmatis, as a possible model for Mycobacterium tuberculosis","volume":"13","author":"T","year":"2020","journal-title":"J. Infect. Public Health"},{"issue":"1","key":"10.1016\/j.bioorg.2021.105489_b0225","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1186\/s12864-017-3924-y","article-title":"Phenotypic and genomic comparison of Mycobacterium aurum and surrogate model species to Mycobacterium tuberculosis: implications for drug discovery","volume":"18","author":"Namouchi","year":"2017","journal-title":"BMC Genomics"},{"issue":"6","key":"10.1016\/j.bioorg.2021.105489_b0230","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2323\/jgam.53.333","article-title":"Evaluation of Mycobacterium smegmatis as a possible surrogate screen for selecting molecules active against multi-drug resistant Mycobacterium tuberculosis","volume":"53","author":"Chaturvedi","year":"2007","journal-title":"J. Gen. Appl. Microbiol."},{"issue":"9","key":"10.1016\/j.bioorg.2021.105489_b0235","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1128\/AAC.48.9.3412-3418.2004","article-title":"Genes required for intrinsic multidrug resistance in Mycobacterium avium","volume":"48","author":"Philalay","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bioorg.2021.105489_b0240","doi-asserted-by":"crossref","unstructured":"European Committee for Antimicrobial Susceptibility Testing (EUCAST) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Determination of minimum inhibitory concentrations (MICs) of antibacterial agents by broth dilution, Clin. Microbiol. Infect., 9 (2003) ix-xv.","DOI":"10.1046\/j.1469-0691.2003.00790.x"},{"key":"10.1016\/j.bioorg.2021.105489_b0245","unstructured":"EUCAST DEFINITIVE DOCUMENT E.DEF 7.3.1., Method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts. 2017. URL: http:\/\/www.eucast.org\/astoffungi\/methodsinantifungalsusceptibilitytesting\/susceptibility_testing_of_yeasts\/."},{"key":"10.1016\/j.bioorg.2021.105489_b0250","unstructured":"EUCAST DEFINITIVE DOCUMENT E.DEF 9.3.1., Method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia forming moulds. 2017. URL: http:\/\/www.eucast.org\/astoffungi\/methodsinantifungalsusceptibilitytesting\/susceptibility_testing_of_moulds\/."},{"issue":"7","key":"10.1016\/j.bioorg.2021.105489_b0255","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1021\/acsmedchemlett.0c00173","article-title":"2-Aminooxazole as a Novel Privileged Scaffold in Antitubercular Medicinal Chemistry","volume":"11","author":"Azzali","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"issue":"2","key":"10.1016\/j.bioorg.2021.105489_b0260","doi-asserted-by":"crossref","first-page":"102","DOI":"10.4331\/wjbc.v8.i2.102","article-title":"Common therapeutic target for both cancer and obesity","volume":"8","author":"Chang","year":"2017","journal-title":"World J. Biol. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206821008671?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206821008671?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:23:28Z","timestamp":1758615808000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206821008671"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":52,"alternative-id":["S0045206821008671"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2021.105489","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and biological evaluation of substituted 3-amino-N-(thiazol-2-yl)pyrazine-2-carboxamides as inhibitors of mycobacterial methionine aminopeptidase 1","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2021.105489","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105489"}}